E

Envista Holdings Corp
NYSE:NVST

Watchlist Manager
Envista Holdings Corp
NYSE:NVST
Watchlist
Price: 18.95 USD 0.8% Market Closed
Market Cap: 3.3B USD
Have any thoughts about
Envista Holdings Corp?
Write Note

Envista Holdings Corp
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Envista Holdings Corp
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
E
Envista Holdings Corp
NYSE:NVST
Cash from Operating Activities
$275.7m
CAGR 3-Years
-1%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cash from Operating Activities
$3.8B
CAGR 3-Years
-6%
CAGR 5-Years
3%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Cash from Operating Activities
$2.9B
CAGR 3-Years
12%
CAGR 5-Years
20%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Cash from Operating Activities
$3.8B
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Cash from Operating Activities
$8.7B
CAGR 3-Years
-8%
CAGR 5-Years
10%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash from Operating Activities
$1.8B
CAGR 3-Years
-5%
CAGR 5-Years
6%
CAGR 10-Years
10%
No Stocks Found

Envista Holdings Corp
Glance View

Market Cap
3.3B USD
Industry
Health Care

Envista Holdings Corp., a prominent player in the dental industry, spins a captivating narrative of innovation and expertise. Emerging from a legacy rooted in the exceptional engineering standards of Danaher Corporation, Envista was formed to focus sharply on dental products and solutions. Its operational structure is divided into three main segments: Specialty Products & Technologies, Orthodontic Products, and Equipment & Consumables. With a strategic emphasis on orthodontics and endodontics, the company engineers advanced technological solutions such as clear aligners, imaging software, and digital treatment planning tools. This specialization is key to its operations, allowing Envista to cater to dental practitioners' diverse needs with products that boost the efficiency and precision of dental treatments. Revenue generation for Envista hinges upon its broad portfolio of trusted brands, including KaVo Kerr, Nobel Biocare, and Ormco, which are synonymous with quality in the dental field. Through these brands, Envista not only manufactures and sells premium dental equipment and supplies, but also provides comprehensive services from maintenance and repair to educational support. The company utilizes a robust distribution network and partners with dental service organizations globally, ensuring its products reach a wide audience. Furthermore, Envista’s commitment to research and development fuels its profitability by continually offering state-of-the-art solutions that meet the evolving demands of the dental industry. This relentless focus on innovation and customer-centric approaches underpin its financial performance, positioning Envista as a formidable force in its market.

NVST Intrinsic Value
25.34 USD
Undervaluation 25%
Intrinsic Value
Price
E

See Also

What is Envista Holdings Corp's Cash from Operating Activities?
Cash from Operating Activities
275.7m USD

Based on the financial report for Dec 31, 2023, Envista Holdings Corp's Cash from Operating Activities amounts to 275.7m USD.

What is Envista Holdings Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-7%

Over the last year, the Cash from Operating Activities growth was 51%. The average annual Cash from Operating Activities growth rates for Envista Holdings Corp have been -1% over the past three years , -7% over the past five years .

Back to Top